The lipophilic opioids: Fentanyl, alfentanil, sufentanil and remifentanil


Autoria(s): Hall, Anthony; Hardy, Janet
Contribuinte(s)

Davis, Mellar P.

Glare, Paul A.

Hardy, Janet

Quigley, Columba

Data(s)

2009

Resumo

discusses fentanyl, alfentanil, sufentanil, and remifentanil which are synthetic opioid analgesics with high affinity for the mu opioid receptor. They have been widely adopted in anaesthetic practice for various surgical procedures (e.g. in cardiac surgery) and for long-term analgesia and sedation. Important pharmacokinetic differences between these analgesics have been described, and this chapter addresses how the pharmacokinetic profile of each analgesic is affected by many factors, including patient age, plasma protein content, acid–base balance status, cardiopulmonary bypass, changes in hepatic blood flow, and the co-administration of other drugs which compete for plasma protein carriers and metabolic pathways, although their profile is not significantly affected by renal insufficiency or compensated hepatic dysfunction, which has major clinical implications.

Identificador

http://eprints.qut.edu.au/84378/

Publicador

Oxford University Press

Relação

http://ukcatalogue.oup.com/product/9780199236640.do

DOI:10.1093/med/9780199236640.003.0011

Hall, Anthony & Hardy, Janet (2009) The lipophilic opioids: Fentanyl, alfentanil, sufentanil and remifentanil. In Davis, Mellar P., Glare, Paul A., Hardy, Janet, & Quigley, Columba (Eds.) Opioids in Cancer Pain [2nd.]. Oxford University Press, Oxford , UK.

Fonte

Faculty of Health; Institute of Health and Biomedical Innovation

Tipo

Book Chapter